Skip to main content

Table 1 Baseline Characteristics of Patients with PMD and Non-PMD

From: The association between high-sensitivity C-reactive protein at admission and progressive motor deficits in patients with penetrating artery infarctions

Variable

PMD (n = 85)

Non-PMD (n = 459)

P

Demographic characteristics

 Age, years

67.8 ± 11.6

64.9 ± 11.8

0.038

 Male, %

60 (70.6)

327 (71.2)

0.903

Vascular risk factors, %

 Hypertension

56 (65.9)

304 (66.2)

0.950

 Diabetes mellitus

44 (51.8)

117 (25.5)

< 0.001

 Dyslipidemia

15 (17.6)

76 (16.6)

0.805

 Current smoking

30 (35.3)

191 (41.6)

0.276

 Current drinking

19 (22.4)

143 (31.2)

0.197

 Previous stroke

7 (8.2)

60 (13.1)

0.213

 Peripheral artery disease

4 (4.7)

12 (2.6)

0.294

 Coronary artery disease

12 (14.1)

54 (11.8)

0.542

Clinical data

 Previous antiplatelet, %

10 (11.8)

47 (10.2)

0.673

 Previous statin, %

2 (2.4)

14 (3.1)

0.727

 SBP, mmHg

142.8 ± 19.8

144.9 ± 20.8

0.445

 DBP, mmHg

84.7 ± 11.7

86.0 ± 12.4

0.449

 Body mass index, kg/m2

24.3 ± 4.3

24.5 ± 3.3

0.773

 Initial total NIHSS, score

3 (1–4)

2 (2–4)

0.728

 White matter lesions, %

60 (70.6)

294 (64.1)

0.246

 Intravenous thrombolysis, %

15 (17.6)

76 (16.6)

0.805

 Infra-tentorial infarction, %

42 (49.4)

244 (53.2)

0.525

 Supra-tentorial infarction, %

43 (50.6)

215 (46.8)

0.525

 MCA stenosis, %

  0

46 (54.1)

261 (56.9)

0.639

   ≤ 50%

35 (41.2)

173 (37.7)

0.544

  >50%

4 (4.7)

25 (5.4)

0.780

 VBA stenosis, %

  0

40 (47.1)

258 (56.2)

0.577

   ≤ 50%

31 (36.5)

172 (37.5)

0.861

  >50%

9 (10.6)

30 (6.5)

0.183

 Carotid artery atheromatosis, %

  Absence

39 (45.9)

183 (39.9)

0.300

  Moderate

39 (45.9)

239 (52.7)

0.295

  Significant

7 (8.2)

37 (8.1)

0.957

 Silent lacunar infarcts, %

42 (49.4)

204 (44.4)

0.398

 OMT, day

1 (1,2)

1 (1,2)

0.589

 Antibiotic use, %

23 (27.1)

92 (20.0)

0.146

Laboratory data

 Leukocyte number, 10^9

8.5 ± 2.4

8.0 ± 4.3

0.348

 TC, mmol/L

4.4 ± 1.2

4.5 ± 1.0

0.338

 TG, mmol/L

2.0 ± 1.4

1.7 ± 1.1

0.073

 HDL, mmol/L

1.0 ± 0.2

1.1 ± 0.4

0.306

 LDL, mmol/L

2.7 ± 0.8

2.7 ± 0.8

0.902

 FBG, mmol/L

7.5 ± 3.5

5.7 ± 2.1

< 0.001

 Glycated hemoglobin, %

7.5 ± 2.4

6.2 ± 1.3

0.002

 Homocysteine, umol/L

15.6 ± 8.0

16.1 ± 8.3

0.519

 Hs-CRP, mg/L

5.9 (4.0–9.8)

2.0 (1.3–3.8)

< 0.001

  1. Abbreviations: SBP, Systolic blood pressure; DBP, Diastolic blood pressure; National Institutes of Health Stroke Scale; MCA, Middle cerebral artery; VBA, Vertebro-basilar artery; OMT, Onset to the measurement of hs-CRP time; TC, Total cholesterol; TG, Triglyceride; HDL, High density lipoprotein; LDL, Low density lipoprotein; FBG, Fast blood glucose
  2. ‘Antibiotic use’ means ‘the antibiotic use during hospitalisation’